We are live on ! Find out more
LLY icon

Eli Lilly

3,907 hedge funds and large institutions have $610B invested in Eli Lilly in 2025 Q2 according to their latest regulatory filings, with 218 funds opening new positions, 1,772 increasing their positions, 1,451 reducing their positions, and 174 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $14.1B | Put options by funds: $10.7B

25% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 174

22% more repeat investments, than reductions

Existing positions increased: 1,772 | Existing positions reduced: 1,451

0% less funds holding

Funds holding: 3,9203,907 (-13)

5.58% less ownership

Funds ownership: 88.24%82.66% (-5.6%)

12% less capital invested

Capital invested by funds: $689B → $610B (-$79.3B)

27% less funds holding in top 10

Funds holding in top 10: 399291 (-108)

Holders
3,907
Holders Change
-13
Holders Change %
-0.33%
% of All Funds
51.43%
Holding in Top 10
291
Holding in Top 10 Change
-108
Holding in Top 10 Change %
-27.07%
% of All Funds
3.83%
New
218
Increased
1,772
Reduced
1,451
Closed
174
Calls
$14.1B
Puts
$10.7B
Net Calls
+$3.4B
Net Calls Change
+$4.07B
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$4.06B -$179M -230,065 -4%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.05B -$299M -384,456 -7%
Franklin Resources
28
Franklin Resources
California
$3.72B +$439M +564,736 +13%
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$3.42B -$115M -147,750 -3%
Fisher Asset Management
30
Fisher Asset Management
Washington
$3.35B -$883M -1,135,979 -21%
UBS Group
31
UBS Group
Switzerland
$3.06B +$62.6M +80,555 +2%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$2.99B +$23M +29,553 +0.8%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$2.88B -$82.4M -106,021 -3%
Amundi
34
Amundi
France
$2.78B -$1.08B -1,391,901 -28%
Deutsche Bank
35
Deutsche Bank
Germany
$2.73B -$820K -1,055 -0%
Invesco
36
Invesco
Georgia
$2.52B -$1.5M -1,928 -0.1%
Wells Fargo
37
Wells Fargo
California
$2.43B +$119M +153,508 +5%
Ameriprise
38
Ameriprise
Minnesota
$2.27B -$32.3M -41,585 -1%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.9B +$127M +163,400 +7%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.57B +$219M +281,862 +16%
HSBC Holdings
41
HSBC Holdings
United Kingdom
$1.55B -$107M -137,921 -6%
Edgewood Management
42
Edgewood Management
Connecticut
$1.55B -$79.4M -102,196 -5%
Sumitomo Mitsui Trust Group
43
Sumitomo Mitsui Trust Group
Japan
$1.51B -$15.8M -20,348 -1%
Schroder Investment Management Group
44
Schroder Investment Management Group
United Kingdom
$1.49B +$138M +177,127 +10%
American Century Companies
45
American Century Companies
Missouri
$1.43B -$104M -134,128 -7%
Polen Capital Management
46
Polen Capital Management
Florida
$1.35B -$12.9M -16,661 -0.9%
Mitsubishi UFJ Asset Management
47
Mitsubishi UFJ Asset Management
Japan
$1.23B +$80.6M +103,708 +7%
Victory Capital Management
48
Victory Capital Management
Texas
$1.22B +$706M +908,225 +138%
Neuberger Berman Group
49
Neuberger Berman Group
New York
$1.21B +$29.3M +37,679 +2%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.21B -$36M -46,353 -3%

LLY Hedge Fund Activity: Q2 2025 in Review

3,907 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2025, worth a combined $610B — down 12% from $689B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new LLY positions and 174 closed out — a net gain of 44 holders — while 1,772 added to existing stakes and 1,451 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $3.89B. The largest seller was PNC Financial Services Group, cutting an estimated $38.9B.

  • 3,907 institutional investors held Eli Lilly (LLY) as of Q2 2025, down from 3,920 in Q1 2025.
  • Funds reported $610B of Eli Lilly stock for Q2 2025, down 12% quarter-over-quarter.
  • 218 funds opened new Eli Lilly positions in Q2 2025 and 174 closed out, a net change of +44 holders.
  • The largest Eli Lilly buyer in Q2 2025 was Capital Research Global Investors, an estimated $3.89B added.
  • The largest Eli Lilly seller in Q2 2025 was PNC Financial Services Group, an estimated $38.9B sold.

Based on aggregated 13F filings for Q2 2025.